296 related articles for article (PubMed ID: 18990612)
1. The impact of alternative treatment for abnormal uterine bleeding on hysterectomy rates in a tertiary referral center.
van Dongen H; van de Merwe AG; de Kroon CD; Jansen FW
J Minim Invasive Gynecol; 2009; 16(1):47-51. PubMed ID: 18990612
[TBL] [Abstract][Full Text] [Related]
2. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal.
Henriquez DD; van Dongen H; Wolterbeek R; Jansen FW
J Minim Invasive Gynecol; 2007; 14(1):59-63. PubMed ID: 17218231
[TBL] [Abstract][Full Text] [Related]
3. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy.
Vilos GA; Tureanu V; Garcia M; Abu-Rafea B
J Minim Invasive Gynecol; 2009; 16(4):480-4. PubMed ID: 19573825
[TBL] [Abstract][Full Text] [Related]
4. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
5. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
7. Current treatment of dysfunctional uterine bleeding.
Bongers MY; Mol BW; Brölmann HA
Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
[TBL] [Abstract][Full Text] [Related]
8. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation.
Loffer FD
J Minim Invasive Gynecol; 2005; 12(3):254-60. PubMed ID: 15922984
[TBL] [Abstract][Full Text] [Related]
9. The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women.
Jindabanjerd K; Taneepanichskul S
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S147-51. PubMed ID: 17726816
[TBL] [Abstract][Full Text] [Related]
10. Hysteroscopic sterilization in patients with a Mirena intrauterine device: transition from extended interval to permanent contraception.
Tatalovich JM; Anderson TL
J Minim Invasive Gynecol; 2010; 17(2):228-31. PubMed ID: 20226413
[TBL] [Abstract][Full Text] [Related]
11. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
12. Miscellaneous uterine malignant neoplasms detected during hysteroscopic surgery.
Vilos GA; Edris F; Abu-Rafea B; Hollett-Caines J; Ettler HC; Al-Mubarak A
J Minim Invasive Gynecol; 2009; 16(3):318-25. PubMed ID: 19423062
[TBL] [Abstract][Full Text] [Related]
13. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
Milsom I
Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
[TBL] [Abstract][Full Text] [Related]
14. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
[TBL] [Abstract][Full Text] [Related]
15. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
16. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
Lukes AS; Reardon B; Arepally G
Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
[TBL] [Abstract][Full Text] [Related]
18. [Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study].
Yazbeck C; Omnes S; Vacher-Lavenu MC; Madelenat P
Gynecol Obstet Fertil; 2006 Oct; 34(10):906-13. PubMed ID: 16987684
[TBL] [Abstract][Full Text] [Related]
19. Hysteroscopic surgery does not adversely affect the long-term prognosis of women with endometrial adenocarcinoma.
Vilos GA; Edris F; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(2):205-10. PubMed ID: 17368258
[TBL] [Abstract][Full Text] [Related]
20. Combined transcervical endometrial resection and levonorgestrel device treatment compared to transcervical endometrial resection for abnormal uterine bleed.
Darre Haahr P; Nielsen NB; Grunnet I; Rudnicki M
Acta Obstet Gynecol Scand; 2020 Nov; 99(11):1554-1560. PubMed ID: 32609875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
